| 2026 | 2025 | ||
| Notes | £m | £m* | |
Revenue | 2, 3 | ||
Cost of sales | 2 | ( | ( |
Gross profit | |||
Distribution costs | ( | ( | |
Administrative expenses | ( | ( | |
Profit on disposal of businesses | 27 | ||
Gain on significant legal proceedings | 4 | ||
Major impairment and restructuring charges | 4, 6 | ( | ( |
Operating profit | 2, 4 | ||
Finance costs | 8 | ( | ( |
Investment income | 8 | ||
Share of (losses) / profits of associates | 15 | ( | |
Profit before tax from continuing operations | |||
Tax expense | 9 | ( | ( |
(Loss) / profit for the year from continuing operations | ( | ||
(Loss) / profit after tax from discontinued operations | ( | ||
(Loss) / profit for the year | ( | ||
pence | pence | ||
| (Loss) / earnings per ordinary share | |||
Basic | 10 | ( | |
Diluted | 10 | ( | |
| (Loss) / earnings per ordinary share from continuing operations | |||
Basic | 10 | ( | |
Diluted | 10 | ( |
| 2026 | 2025 | ||
| Notes | £m | £m | |
(Loss) / profit for the year | ( | ||
| Other comprehensive (expense) / income | |||
| Items that will not be reclassified to the income statement in subsequent years | |||
Remeasurements of post-employment benefit assets and liabilities | 24 | ( | |
Fair value losses on equity investments at fair value through other comprehensive income | ( | ||
Tax on items that will not be reclassified to the income statement 1 | ( | ||
Total items that will not be reclassified to the income statement | ( | ||
| Items that may be reclassified to the income statement | |||
Exchange differences on translation of foreign operations | 25 | ( | ( |
Amounts charged to hedging reserve | 25 | ( | ( |
Fair value (losses) / gains on net investment hedges | ( | ||
Tax on above items taken directly to or transferred from equity 2 | |||
Total items that may be reclassified to the income statement in subsequent years | ( | ( | |
Other comprehensive expense for the year | ( | ( | |
Total comprehensive (expense) / income for the year | ( | ||
| Total comprehensive (expense) / income for the year arises from: | |||
Continuing operations | ( | ||
Discontinued operations | 26 | ( | |
( |
| 2026 | 2025 | ||
| Notes | £m | £m | |
| Assets | |||
| Non-current assets | |||
Property, plant and equipment | 11 | ||
Right-of-use assets | 12 | ||
Goodwill | 13 | ||
Other intangible assets | 14 | ||
Investments in associates | 15 | ||
Investments at fair value through other comprehensiveincome | 28 | ||
Other receivables | 17 | ||
Derivative financial instruments | 18 | ||
Deferred tax assets | 23 | ||
Post-employment benefit net assets | 24 | ||
Total non-current assets | |||
| Current assets | |||
Inventories | 16 | ||
Taxation recoverable | |||
Trade and other receivables | 17 | ||
Financial assets held at amortised cost | |||
Cash and cash equivalents | |||
Derivative financial instruments | 18 | ||
Assets classified as held for sale | 26 | ||
Total current assets | |||
Total assets |
| 2026 | 2025 | ||
| Notes | £m | £m | |
| Liabilities | |||
| Current liabilities | |||
Trade and other payables | 19 | ( | ( |
Lease liabilities | 12 | ( | ( |
Taxation liabilities | ( | ( | |
Cash and cash equivalents – bank overdrafts | ( | ( | |
Borrowings | 20 | ( | ( |
Derivative financial instruments | 18 | ( | ( |
Provisions | 22 | ( | ( |
Liabilities classified as held for sale | 26 | ( | |
Total current liabilities | ( | ( | |
| Non-current liabilities | |||
Borrowings | 20 | ( | ( |
Lease liabilities | 12 | ( | ( |
Deferred tax liabilities | 23 | ( | ( |
Employee benefit obligations | 24 | ( | ( |
Derivative financial instruments | 18 | ( | ( |
Provisions | 22 | ( | ( |
Trade and other payables | 19 | ( | ( |
Total non-current liabilities | ( | ( | |
Total liabilities | ( | ( | |
Net assets | |||
| Equity | |||
Share capital | 25 | ||
Share premium | |||
Treasury shares | ( | ( | |
Other reserves | 25 | ( | ( |
Retained earnings | |||
Total equity |
| 2026 | 2025 | ||
| Notes | £m | £m* | |
| Cash flows from operating activities | |||
Profit before tax from continuing operations | |||
| Adjustments for: | |||
Share of losses / (profits) of associates | ( | ||
Profit on disposal of businesses | ( | ( | |
Depreciation | |||
Amortisation | |||
Impairment losses | |||
Profit on sale of non-current assets | ( | ||
Share-based payments | |||
(Increase) / decrease in inventories | ( | ||
(Increase) / decrease in receivables | ( | ||
Increase / (decrease) in payables | ( | ||
(Decrease) / increase in provisions | ( | ||
| Contributions less than / (in excess of) employee benefit | |||
obligations charge | ( | ||
Changes in fair value of financial instruments | ( | ||
Net finance costs | |||
Disposal costs | ( | ( | |
Income tax paid | ( | ( | |
| Net cash (outflow) / inflow from operating activities – | |||
discontinued operations | 26 | ( | |
Net cash inflow from operating activities | |||
| Cash flows from investing activities | |||
Interest received | |||
Purchases of property, plant and equipment | ( | ( | |
Purchases of intangible assets | ( | ( | |
Proceeds from redemption of investments held at fair value through other comprehensive income | |||
Net cash movements of financial assets held at amortised cost | ( | ||
Proceeds from sale of non-current assets | |||
Proceeds from sale of businesses | 27 | ||
| Net cash outflow from investing activities – discontinued | |||
operations | 26 | ( | ( |
Net cash (outflow) / inflow from investing activities | ( |
| 2026 | 2025 | ||
| Notes | £m | £m* | |
| Cash flows from financing activities | |||
Purchase of treasury shares | ( | ||
Proceeds from borrowings | |||
Repayment of borrowings | ( | ( | |
Net cash movements from hedging activities | |||
Dividends paid to equity shareholders | 25 | ( | ( |
Interest paid | ( | ( | |
Principal element of lease payments | ( | ( | |
| Net cash outflow from financing activities – discontinued | |||
operations | 26 | ( | ( |
Net cash outflow from financing activities | ( | ( | |
Change in cash and cash equivalents | ( | ||
Exchange differences on cash and cash equivalents | ( | ||
Cash and cash equivalents at beginning of year | |||
Cash and deposits transferred to assets classified as held forsale | 26 | ( | |
Cash and cash equivalents at end of year | |||
Cash and deposits | |||
Money market funds | |||
Bank overdrafts | ( | ( | |
Cash and deposits transferred to assets classified as held forsale | 26 | ( | |
Cash and cash equivalents |
| Other | ||||||
| Share | Share | Treasury | reserves | Retained | Total | |
| capital | premium | shares | (note 25) | earnings | equity | |
| £m | £m | £m | £m | £m | £m | |
At 1 st April 2024 | ( | |||||
Profit for the year | ||||||
Remeasurements of post-employment benefit assets and liabilities | ||||||
Fair value losses on investments at fair value through other comprehensive income | ( | ( | ||||
Exchange differences on translation of foreign operations | ( | ( | ||||
Amounts charged to hedging reserve | ( | ( | ||||
Fair value gains on net investment hedges taken to equity | ||||||
Tax on other comprehensive (expense) / income | ( | |||||
Total comprehensive (expense) / income | ( | |||||
Dividends paid (note 25) | ( | ( | ||||
Purchase of treasury shares (note 25) | ( | ( | ( | |||
Share-based payments | ||||||
Cost of shares transferred to employees | ( | ( | ||||
At 31 st March 2025 | ( | ( | ||||
Loss for the year | ( | ( | ||||
Remeasurements of post-employment benefit assets and liabilities | ( | ( | ||||
Exchange differences on translation of foreign operations | ( | ( | ||||
Amounts charged to hedging reserve | ( | ( | ||||
Fair value losses on net investment hedges taken to equity | ( | ( | ||||
Tax on other comprehensive expense | ||||||
Total comprehensive expense | ( | ( | ( | |||
Dividends paid (note 25) | ( | ( | ||||
Share-based payments | ||||||
Cost of shares transferred to employees | ( | ( | ||||
At | ( | ( |
| Continuing operations | ||||||
| Hydrogen | ||||||
| Clean Air | PGM Services | Technologies | Corporate | Eliminations | Total | |
| £m | £m | £m | £m | £m | £m | |
Revenue from external customers | 3,778 | 8,715 | 80 | – | – | 12,573 |
Inter-segment revenue | – | 1,579 | – | – | (1,579) | – |
Revenue | 3,778 | 10,294 | 80 | – | (1,579) | 12,573 |
Cost of sales – precious metal to customers | (1,655) | (9,874) | (9) | – | 1,520 | (10,018) |
Cost of sales – non-precious metal | (1,692) | (224) | (58) | (12) | 60 | (1,926) |
Cost of sales | (3,347) | (10,098) | (67) | (12) | 1,580 | (11,94 4) |
External sales | 2,123 | 361 | 71 | – | – | 2,555 |
Inter-segment sales | – | 59 | – | – | (59) | – |
Sales 1 | 2,123 | 420 | 71 | – | (59) | 2,555 |
Underlying operating profit / (loss) 1 | 307 | 119 | (19) | (67) | – | 340 |
| Continuing operations | |||||||
| PGM Services | Hydrogen | ||||||
| Clean Air | (restated) | Technologies | Value Businesses | Corporate | Eliminations | Total | |
| £m | £m | £m | £m | £m | £m | £m | |
Revenue from external customers | 3,973 | 6,930 | 68 | 51 | – | – | 11,022 |
Inter-segment revenue | – | 1,485 | – | – | – | (1,485) | – |
Revenue | 3,973 | 8,415 | 68 | 51 | – | (1,485) | 11,022 |
Cost of sales – precious metal to customers | (1,654) | (7,934) | (8) | (14) | – | 1,419 | (8,191) |
Cost of sales – non-precious metal | (1,856) | (235) | (68) | (32) | (22) | 66 | (2,147) |
Cost of sales | (3,510) | (8,169) | (76) | (46) | (22) | 1,485 | (10,338) |
External sales | 2,319 | 415 | 60 | 37 | – | – | 2,831 |
Inter-segment sales | – | 66 | – | – | – | (66) | – |
Sales 1 | 2,319 | 481 | 60 | 37 | – | (66) | 2,831 |
Underlying operating profit / (loss) 1 | 273 | 151 | (39) | 1 | (87) | – | 299 |
| Continuing operations | |||||
| Hydrogen | |||||
| Clean Air | PGM Services | Technologies | Corporate | Total | |
| £m | £m | £m | £m | £m | |
Underlying operating profit / (loss) 1 | 307 | 119 | (19) | (67) | 340 |
Profit on disposal of businesses | – | – | – | 5 | 5 |
Gain on significant legal proceedings | – | – | – | 8 | 8 |
Major impairment and restructuring charges (note 6) | (23) | (55) | (89) | (25) | (192) |
Operating profit / (loss) | 284 | 64 | (108) | (79) | 161 |
| Continuing operations | ||||||
| PGM Services | Hydrogen | Value | ||||
| Clean Air | (restated) | Technologies | Businesses | Corporate | Total | |
| £m | £m | £m | £m | £m | £m | |
Underlying operating profit / (loss) 1 | 273 | 151 | (39) | 1 | (87) | 299 |
(Loss) / profit on disposal of businesses | – | (19) | – | 29 | 472 | 482 |
Major impairment and restructuring charges | (39) | (63) | (145) | (1) | (79) | (327) |
Operating profit / (loss) | 234 | 69 | (184) | 29 | 306 | 454 |
| PGM | Hydrogen | ||||
| Clean Air | Services | Technologies | Corporate | Total | |
| £m | £m | £m | £m | £m | |
Segmental net assets | 1,494 | (11) | 73 | 276 | 1,832 |
Net debt (note 34) | (880) | ||||
Post-employment benefit net assets and liabilities | 202 | ||||
Deferred tax net assets | 29 | ||||
Provisions and non-current other payables | (75) | ||||
Investments in associates (note 15) | 70 | ||||
Net assets held for sale (note 26) | 838 | ||||
Net assets | 2,016 | ||||
Property, plant and equipment | 27 | 153 | 4 | 12 | 196 |
Intangible assets | 1 | 11 | – | 8 | 20 |
Capital expenditure | 28 | 164 | 4 | 20 | 216 |
Depreciation | 64 | 25 | 2 | 12 | 103 |
Amortisation | 4 | 2 | – | 40 | 46 |
Impairment losses (notes 5 and 6) | 9 | 38 | 89 | – | 136 |
Total | 77 | 65 | 91 | 52 | 285 |
| Catalyst | ||||||
| PGM Services | Technologies | Hydrogen | ||||
| Clean Air | (restated) | (restated) | Technologies | Corporate | Total | |
| £m | £m | £m | £m | £m | £m | |
Segmental net assets | 1,345 | 144 | 778 | 153 | 373 | 2,793 |
Net debt | (799) | |||||
Post-employment benefit net assets and liabilities | 200 | |||||
Deferred tax net asset | 131 | |||||
Provisions and non-current other payables | (101) | |||||
Investments in associates (note 15) | 71 | |||||
Net assets | 2,295 | |||||
Property, plant and equipment | 33 | 185 | – | 25 | 10 | 253 |
Intangible assets | 5 | 11 | – | 2 | 32 | 50 |
Capital expenditure | 38 | 196 | – | 27 | 42 | 303 |
Depreciation | 67 | 24 | – | 5 | 15 | 111 |
Amortisation | 5 | 2 | – | – | 38 | 45 |
Impairment losses (notes 5 and 6) | 25 | 39 | – | 134 | 18 | 216 |
Total | 97 | 65 | – | 139 | 71 | 372 |
Sub-business | Primary industry | Principal products and services | Performance obligations | Revenue recognition |
| Clean Air | ||||
Light Duty Catalysts | Automotive | Catalysts for cars and other light duty vehicles | Point in time | On despatch or delivery |
Heavy Duty Catalysts | Automotive | Catalysts for trucks, buses and non-road equipment | Point in time | On despatch or delivery |
| PGM Services | ||||
| Platinum Group | Various | Platinum Group Metal refining and recycling services | Over time | Based on output |
| Metal Services | Platinum Group Metal trading | Point in time | On receipt of payment or metal | |
| being available to customer | ||||
Other precious metal products | Point in time | On despatch or delivery | ||
Platinum Group Metal chemical, industrial products and catalysts | Point in time | On despatch or delivery | ||
| Hydrogen Technologies | ||||
Fuel Cell and Electrolyser Technology | Various | Fuel Cell and Electrolyser catalyst coated membrane | Point in time | On despatch or delivery |
| Continuing operations | ||||
| PGM | Hydrogen | |||
| Clean Air | Services | Technologies | Total | |
| £m | £m | £m | £m | |
Metal | 1,655 | 8,354 | 9 | 10,018 |
Heavy Duty Catalysts | 729 | – | – | 729 |
Light Duty Catalysts | 1,394 | – | – | 1,394 |
Platinum Group Metal Services | – | 361 | – | 361 |
Fuel Cell and Electrolyser Technology | – | – | 71 | 71 |
Revenue | 3,778 | 8,715 | 80 | 12,573 |
| Continuing operations | |||||
| PGM | |||||
| Services | Hydrogen | ||||
| Clean Air | (restated) | Technologies | Value Businesses | Total | |
| £m | £m | £m | £m | £m | |
Metal | 1,654 | 6,515 | 8 | 14 | 8,191 |
Heavy Duty Catalysts | 790 | – | – | – | 790 |
Light Duty Catalysts | 1,529 | – | – | – | 1,529 |
Platinum Group Metal Services | – | 415 | – | – | 415 |
Fuel Cell and Electrolyser Technology | – | – | 60 | – | 60 |
Battery Systems | – | – | – | 15 | 15 |
Medical Device Components | – | – | – | 21 | 21 |
Other | – | – | – | 1 | 1 |
Revenue | 3,973 | 6,930 | 68 | 51 | 11,022 |
| Continuing operations | ||||
| PGM | Hydrogen | |||
| Clean Air | Services | Technologies | Total | |
| £m | £m | £m | £m | |
Revenue recognised at a point in time | 3,778 | 8,433 | 80 | 12,291 |
Revenue recognised over time | – | 282 | – | 282 |
Revenue | 3,778 | 8,715 | 80 | 12,573 |
| Continuing operations | |||||
| PGM | |||||
| Services | Hydrogen | ||||
| Clean Air | (restated) | Technologies | Value Businesses | Total | |
| £m | £m | £m | £m | £m | |
Revenue recognised at a point in time | 3,973 | 6,695 | 68 | 49 | 10,785 |
Revenue recognised over time | – | 235 | – | 2 | 237 |
Revenue | 3,973 | 6,930 | 68 | 51 | 11,022 |
Revenue from external customers | Non-current assets | |||
| 2026 | 2025 | 2026 | 2025 | |
| £m | £m* | £m | £m | |
UK | 4,514 | 4,057 | 854 | 1,082 |
Germany | 747 | 850 | 131 | 214 |
Rest of Europe | 1,053 | 1,005 | 186 | 300 |
USA | 2,298 | 1,843 | 274 | 421 |
Rest of North America | 710 | 711 | 97 | 16 |
China (including Hong Kong) | 1,364 | 1,072 | 91 | 103 |
Rest of Asia | 1,638 | 1,232 | 88 | 128 |
Rest of World | 249 | 252 | 4 | 4 |
1,725 | 2,268 | |||
Investments at fair value through other comprehensive income | 36 | 38 | ||
Derivative financial instruments | 2 | 4 | ||
Deferred income tax assets | 43 | 135 | ||
Post-employment benefit net assets | 232 | 238 | ||
Total | 12,573 | 11,022 | 2,038 | 2,683 |
| 2026 | 2025 | |
| £m | £m* | |
Research and development expenditure charged to operating profit | 140 | 160 |
Less: External funding received from governments | (29) | (31) |
Net research and development expenditure charged to operating profit | 111 | 129 |
Inventories recognised as an expense | 11,35 4 | 9,724 |
Past service cost / (credit) 1 | 7 | (12) |
| Depreciation of: | ||
Property, plant and equipment | 98 | 105 |
Right-of-use assets | 5 | 6 |
Depreciation | 103 | 111 |
| Amortisation of: | ||
Other intangible assets | 46 | 45 |
Amortisation | 46 | 45 |
Profit on disposal of businesses (note 27) | (5) | (482) |
Gain on significant legal proceedings | (8) | – |
| 2026 | 2025 | |
| £m | £m* | |
Impairment losses included in major impairment and restructuring charges | 135 | 216 |
Restructuring charges included in major impairment and restructuring charges | 57 | 111 |
Major impairment and restructuring charges (note 6) | 192 | 327 |
| 2026 | 2025 | |
| £m | £m** | |
| Fees payable to the company’s auditor and its associates for: | ||
The audit of the company accounts | 3.1 | 2.9 |
The audit of the accounts of the company’s subsidiaries | 1.8 | 1.9 |
Total audit fees | 4.9 | 4.8 |
Audit-related assurance services | 0.4 | 0.4 |
Total non-audit fees | 0.4 | 0.4 |
Total fees payable to the company’s auditor and its associates | 5.3 | 5.2 |
| 2026 | 2025 | |
| £m | £m | |
| Clean Air | ||
• Heavy Duty Catalysts | 85 | 82 |
Catalyst Technologies | – | 263 |
Other | 1 | 2 |
Total carrying amount at 31 st March (note 13) | 86 | 347 |
Pre-tax discount rate | Long term growth rate | |||
2026 | 2025 | 2026 | 2025 | |
| Clean Air | ||||
• Heavy Duty Catalysts | 12.0% | 13.4% | -11.5% | -11.5% |
| Headroom | Headroom | ||
| Headroom as | assuming a 1% | assuming a 1% | |
at 31 st March | decrease in the | increase in the | |
| 2026 | growth rate | discount rate | |
| £m | £m | £m | |
| Clean Air | |||
• Heavy Duty Catalysts | 329 | 308 | 299 |
| 2026 | 2025 | |
| £m | £m* | |
Property, plant and equipment | 92 | 177 |
Other intangible assets | 4 | 38 |
Inventories | 39 | 1 |
Impairment losses | 135 | 216 |
Restructuring charges | 57 | 111 |
Total major impairments and restructuring charges | 192 | 327 |
2026 | 2025 | |
Clean Air | 4,340 | 4,739 |
PGM Services | 1,920 | 1,950 |
Catalyst Technologies | 2,069 | 1,870 |
Hydrogen Technologies | 368 | 432 |
Value Businesses | – | 156 |
Corporate 1 | 1,340 | 1,497 |
Monthly average number of employees | 10,644 |
| 2026 | 2025 | |
| £m | £m* | |
Wages and salaries | 395 | 441 |
Social security costs | 56 | 60 |
Post-employment costs (note 24) | 51 | 34 |
Share-based payments (note 30) | 12 | 15 |
Termination benefits | 7 | 7 |
Employee benefits expense | 521 | 557 |
| 2026 | 2025 | |
| £m | £m** | |
Net loss on remeasurement of foreign currency swaps held at fair value through profit or loss | (17) | (13) |
Interest payable on financial liabilities held at amortised cost and interest on related swaps | (84) | (72) |
Interest payable on other liabilities 1 | (78) | (53) |
Interest payable on lease liabilities | (2) | (2) |
Interest payable on post-employment benefits | (1) | (1) |
Total finance costs | (182) | (141) |
Net gain on remeasurement of foreign currency swaps held at fair value through profit or loss | 5 | 3 |
Interest receivable on financial assets held at amortised cost | 15 | 17 |
Interest receivable on other assets 1 | 80 | 59 |
Interest receivable on post-employment benefits | 13 | 8 |
Total investment income | 113 | 87 |
Net finance costs | (69) | (54) |
| 2026 | 2025 | |
| £m | £m | |
| Current tax | ||
Corporation tax on profit for the year | 48 | 132 |
Adjustment for prior years | 18 | (19) |
Total current tax | 66 | 113 |
| Deferred tax | ||
Origination and reversal of temporary differences | 123 | 5 |
Adjustment for prior years | – | (5) |
Total deferred tax (note 23) | 123 | – |
Tax expense | 189 | 113 |
| 2026 | 2025 | |
| £m | £m | |
Profit before tax from continuing operations | 91 | 403 |
Profit before tax from discontinued operations | 2 | 83 |
Profit before tax | 93 | 486 |
Tax expense at UK corporation tax rate of 25% (2025: 25%) | 23 | 122 |
| Effects of: | ||
Overseas tax rates | (17) | (16) |
Expenses not deductible for tax purposes | 4 | 48 |
Irrecoverable withholding tax | 18 | 16 |
Losses and other temporary differences not recognised | 92 | 5 |
Previously recognised losses and other temporary differences now not recognised | 84 | 31 |
Adjustment for prior years | 18 | (24) |
Patent box/Innovation box | (13) | (12) |
Other tax incentives | (3) | (8) |
Disposal of businesses | 6 | (48) |
Pillar Two top up tax | 7 | 3 |
Other (see below for further details) | (30) | (4) |
Tax expense | 189 | 113 |
Tax expense from continuing operations | 182 | 93 |
Tax expense from discontinued operations | 7 | 20 |
Tax expense | 189 | 113 |
| 2026 | 2025 | |
| pence | pence | |
| (Loss) / earnings per share | ||
Basic | (57.2) | 211.8 |
Diluted | (56.9) | 211.2 |
Basic from continuing operations | (54.1) | 176.0 |
Diluted from continuing operations | (53.9) | 175.5 |
2026 | 2025 | |
| (Loss) / earnings (£ million) | ||
Basic and diluted (loss) / earnings | (96) | 373 |
| Weighted average number of shares in issue | ||
Basic | 168,153,798 | 175,966,787 |
Dilution for long-term incentive plans | 852,839 | 449,667 |
Diluted | 169,006,637 | 176,416,454 |
| Land and | Leasehold | Plant and | Assets in the course | ||
| buildings | improvements | machinery | of construction | Total | |
| £m | £m | £m | £m | £m | |
| Cost | |||||
At 1 st April 2024 | 591 | 23 | 2,143 | 515 | 3,272 |
Additions | 1 | 1 | 24 | 294 | 320 |
Transfers from assets in the course of construction | 25 | 1 | 123 | (149) | – |
Transfers to other intangible assets (note 14) | – | – | (3) | (18) | (21) |
Reclassification | – | – | – | 2 | 2 |
Disposals | – | (3) | (21) | – | (24) |
Exchange adjustments | (12) | – | (34) | (1) | (47) |
At 31 st March 2025 | 605 | 22 | 2,232 | 643 | 3,502 |
Additions | – | 5 | 16 | 180 | 201 |
Transfers from assets in the course of construction | 4 | 2 | 118 | (124) | – |
Transferred to assets classified as held for sale (note 26) | (58) | (13) | (469) | (78) | (618) |
Reclassification | (4) | 6 | (5) | (1) | (4) |
Disposals | (1) | (1) | (28) | (7) | (37) |
Exchange adjustments | 2 | (1) | 1 | – | 2 |
At 31 st March 2026 | 548 | 20 | 1,865 | 613 | 3,046 |
| Accumulated depreciation and impairment | |||||
At 1 st April 2024 | 290 | 12 | 1,522 | 12 | 1,836 |
Charge for the year | 15 | 1 | 108 | – | 124 |
Impairment losses (notes 5 and 6) 2 | 25 | – | 54 | 100 | 179 |
Reclassification | – | – | 2 | – | 2 |
Disposals | – | (3) | (21) | – | (24) |
Exchange adjustments | (5) | 1 | (22) | – | (26) |
At 31 st March 2025 | 325 | 11 | 1,643 | 112 | 2,091 |
Charge for the year | 12 | 2 | 89 | – | 103 |
Impairment losses (notes 5 and 6) 1 | 3 | – | 52 | 37 | 92 |
Transfers from assets in the course of construction | – | – | 3 | (3) | – |
Transferred to assets classified as held for sale (note 26) | (30) | (4) | (313) | (1) | (348) |
Reclassification | (2) | 3 | (4) | (1) | (4) |
Disposals | (1) | – | (29) | (6) | (36) |
Exchange adjustments | – | – | 1 | – | 1 |
At 31 st March 2026 | 307 | 12 | 1,442 | 138 | 1,899 |
Carrying amount at 31 st March 2026 | 241 | 8 | 423 | 475 | 1,147 |
Carrying amount at 31 st March 2025 | 280 | 11 | 589 | 531 | 1,411 |
Carrying amount at 1 st April 2024 | 301 | 11 | 621 | 503 | 1,436 |
| Land and | Plant and | ||
| buildings | machinery | Total | |
| £m | £m | £m | |
At 1 st April 2024 | 36 | 4 | 40 |
New leases, remeasurements and modifications | 22 | – | 22 |
Depreciation charge for the year | (9) | (1) | (10) |
Impairment losses | (1) | – | (1) |
Exchange adjustments | 1 | 1 | 2 |
At 31 st March 2025 | 49 | 4 | 53 |
New leases, remeasurements and modifications | 5 | 1 | 6 |
Depreciation charge for the year | (4) | (1) | (5) |
Impairment losses 1 | (1) | – | (1) |
Transferred to assets classified as held for sale (note 26) | (20) | (1) | (21) |
Exchange adjustments | 1 | – | 1 |
At 31 st March 2026 | 30 | 3 | 33 |
| 2026 | 2025 | |
| £m | £m | |
Current | 4 | 6 |
Non-current | 24 | 40 |
Total liabilities | 28 | 46 |
| 2026 | 2025 | |
| £m | £m | |
Interest expense | 2 | 2 |
| 2026 | 2025 | |
| £m | £m* | |
Total cash outflow for leases | 4 | 6 |
| £m | |||
| Cost | |||
At 1 st April 2024 | 426 | ||
Exchange adjustments | (6) | ||
At 31 st March 2025 | 420 | ||
Transferred to assets classified as held for sale (note 26) | (263) | ||
Exchange adjustments | 2 | ||
At 31 st March 2026 | 159 | ||
| Accumulated impairment | |||
At 1 st April 2024, | 31 | st March 2025 and 31 st March 2026 | 73 |
Carrying amount at 31 st March 2026 | 86 | ||
Carrying amount at 31 st March 2025 | 347 | ||
Carrying amount at 1 st April 2024 | 353 |
| Customer | Patents, | Acquired | Assets in the | ||||
| contracts and | Computer | trademarks | research and | Development | course of | ||
| relationships | software | and licences | technology | expenditure | construction | Total | |
| £m | £m | £m | £m | £m | £m* | £m | |
| Cost | |||||||
At 1 st April 2024 | 103 | 536 | 32 | 30 | 134 | – | 835 |
Additions | – | 54 | – | – | 2 | – | 56 |
Disposals | – | (1) | – | – | – | – | (1) |
Transfers from property, plant and equipment (note 11) | – | 21 | – | – | – | – | 21 |
Reclassification | – | (3) | – | – | 3 | – | – |
Exchange adjustments | – | – | (1) | – | – | – | (1) |
At 31 st March 2025 | 103 | 607 | 31 | 30 | 139 | – | 910 |
Additions | – | 5 | – | – | – | 15 | 20 |
Reclassifications (to) / from assets in the course of construction | – | (62) | – | – | 1 | 61 | – |
Transferred to assets classified as held for sale (note 26) | (79) | (45) | (24) | (12) | (5) | – | (165) |
Reclassification | – | (1) | 1 | – | – | – | – |
Disposals | – | (17) | – | – | – | – | (17) |
Exchange adjustments | – | – | – | 1 | – | – | 1 |
At 31 st March 2026 | 24 | 487 | 8 | 19 | 135 | 76 | 749 |
| Accumulated amortisation and impairment | |||||||
At 1 st April 2024 | 91 | 252 | 28 | 30 | 133 | – | 534 |
Charge for the year | 3 | 48 | 1 | – | 1 | – | 53 |
Impairment losses (note 6) | – | 38 | – | – | – | – | 38 |
Disposals | – | (1) | – | – | – | – | (1) |
Exchange adjustments | – | – | (1) | – | (1) | – | (2) |
At 31 st March 2025 | 94 | 337 | 28 | 30 | 133 | – | 622 |
Charge for the year | 1 | 45 | – | – | 1 | – | 47 |
Impairment losses 1 | – | 1 | – | – | – | 3 | 4 |
Reclassifications to assets in the course of construction | – | (16) | – | – | – | 16 | – |
Transferred to assets classified as held for sale (note 26) | (70) | (11) | (23) | (13) | – | – | (117) |
Disposals | – | (14) | – | – | – | – | (14) |
Exchange adjustments | (1) | – | – | 2 | – | – | 1 |
At 31 st March 2026 | 24 | 342 | 5 | 19 | 134 | 19 | 543 |
Carrying amount at 31 st March 2026 | – | 145 | 3 | – | 1 | 57 | 206 |
Carrying amount at 31 st March 2025 | 9 | 270 | 3 | – | 6 | – | 288 |
Carrying amount at 1 st April 2024 | 12 | 284 | 4 | – | 1 | – | 301 |
| 2026 | 2025 | |
| £m | £m | |
Investments in associates | 70 | 71 |
| Associates | |
| £m | |
At 1 st April 2024 | 71 |
Group’s share of profit for the year | 3 |
Exchange adjustments | (3) |
At 31 st March 2025 | 71 |
Group’s share of loss for the year | (1) |
At 31 st March 2026 | 70 |
| 2026 | 2025 | |
| £m | £m | |
| Summarised balance sheet | ||
Non-current assets | 126 | 100 |
Cash and cash equivalents | 21 | 28 |
Other current assets | 129 | 153 |
Current assets | 150 | 181 |
Current liabilities | (53) | (55) |
Non-current liabilities | (4) | – |
Net assets | 219 | 226 |
| Summarised statement of comprehensive income | ||
Revenue | 211 | 220 |
Depreciation and amortisation | (13) | (11) |
Income tax expense | – | – |
(Loss) / profit for the year and total comprehensive (expense) / income | (4) | 6 |
| 2026 | 2025 | |
| £m | £m | |
Raw materials and consumables | 170 | 244 |
Work in progress | 562 | 501 |
Finished goods and goods for resale | 133 | 266 |
Inventories | 865 | 1,011 |
| 2026 | 2025 | |
| £m | £m | |
| Current | ||
Trade receivables | 866 | 925 |
Contract receivables | 78 | 53 |
Prepayments | 53 | 70 |
Value added tax and other sales tax receivable 1 | 101 | 116 |
Advance payments to customers | 5 | 7 |
| Amounts receivable under precious metal sale and repurchase | ||
agreements 2 | 217 | 282 |
Other receivables | 110 | 79 |
Trade and other receivables | 1,430 | 1,532 |
| Non-current | ||
Value added tax and other sales tax receivable 1 | 82 | – |
Advance payments to customers | 42 | 40 |
Other receivables | 59 | 58 |
Other receivables | 183 | 98 |
| 2026 | 2025 | |
| £m | £m | |
| Non-current assets | ||
Cross currency and interest rate swaps | 2 | 4 |
Derivative financial instruments | 2 | 4 |
| Current assets | ||
Forward foreign exchange contracts designated as cash flow hedges | 2 | 7 |
Forward precious metal price contracts designated as cash flow hedges | 5 | 31 |
Forward foreign exchange contracts and currency swaps at fair value through profit or loss | 15 | 4 |
Cross currency and interest rate swaps | – | 13 |
Derivative financial instruments | 22 | 55 |
| Current liabilities | ||
Forward foreign exchange contracts designated as cash flow hedges | (4) | (2) |
Forward foreign exchange contracts and currency swaps at fair value through profit or loss | (5) | (11) |
Cross currency and interest rate swaps | – | (1) |
Derivative financial instruments | (9) | (14) |
| Non-current liabilities | ||
Cross currency and interest rate swaps | (13) | (9) |
Derivative financial instruments | (13) | (9) |
| 2026 | 2025 | |
| £m | £m | |
| Current | ||
Trade payables | 658 | 667 |
Contract liabilities | 36 | 105 |
Accruals | 268 | 310 |
Amounts payable under precious metal sale and repurchase agreements 1 | 948 | 669 |
Other payables | 244 | 233 |
Trade and other payables | 2,154 | 1,984 |
| Non-current | ||
Other payables | 7 | 6 |
Trade and other payables | 7 | 6 |
| 2026 | 2025 | |
| £m | £m | |
| Non-current | ||
| Bank and other loans | ||
3.97% $120 million Bonds 2027 | (91) | (93) |
SONIA + 1.25% UKEF EDG £ Facility 2028 | (249) | (250) |
EURIBOR + 1.20% UKEF EDG € Facility 2028 | (156) | (148) |
3.39% $180 million Bonds 2028 | (136) | (138) |
1.81% €90 million Bonds 2028 | (73) | (68) |
2.77% £35 million Bonds 2029 | (35) | (35) |
3.00% $50 million Bonds 2029 | (38) | (39) |
4.10% $30 million Bonds 2030 | (23) | (23) |
2.92% €25 million Bonds 2030 | (22) | (21) |
5.02% $95 million Bonds 2031 | (72) | (73) |
4.03% €125 million Bonds 2031 | (108) | (104) |
1.90% €225 million Bonds 2032 | (195) | (188) |
5.18% $34 million Bonds 2034 | (26) | (26) |
4.19% €94 million Bonds 2034 | (81) | (78) |
4.32% €20 million Bonds 2036 | (17) | (17) |
Borrowings | (1,322) | (1,301) |
| Current | ||
3.14% $130 million Bonds 2025 | – | (100) |
1.40% €77 million Bonds 2025 | – | (63) |
2.54% £45 million Bonds 2025 | – | (45) |
3.79% $130 million Bonds 2025 | – | (100) |
Other bank loans | (20) | (25) |
Borrowings | (20) | (333) |
| Non-cash movements | |||||||
31 st March | Cash (inflow)/ | Transfers to held | Foreign exchange | Fair value and | 31 st March | ||
| 2025 | outflow | Transfers | for sale | movements | other movements | 2026 | |
| £m | £m | £m | £m | £m | £m | £m | |
| Non-current assets | |||||||
Derivative financial instruments – cross currency and interest rate swaps | 4 | – | – | – | (2) | – | 2 |
| Non-current liabilities | |||||||
Borrowings | (1,301) | – | – | – | (19) | (2) | (1,322) |
Derivative financial instruments – cross currency and interest rate swaps | (9) | – | – | – | – | (4) | (13) |
Lease liabilities | (40) | – | 2 | 18 | – | (4) | (24) |
| Current assets | |||||||
Derivative financial instruments – cross currency and interest rate swaps | 13 | (9) | – | – | (3) | (1) | – |
| Current liabilities | |||||||
Borrowings | (333) | 316 | – | – | (1) | (2) | (20) |
Derivative financial instruments – cross currency and interest rate swaps | (1) | – | – | – | – | 1 | – |
Lease liabilities | (6) | 4 | (2) | 1 | – | (1) | (4) |
Net movements in assets and liabilities arising from financing activities | 311 | – | 19 | (25) | (13) | ||
Dividends paid to equity shareholders | 129 | ||||||
Interest paid | 186 | ||||||
Net cash outflow from financing activities – discontinued operations | 4 | ||||||
Net cash outflow from financing activities | 630 |
| Non-cash movements | |||||||
31 st March | Cash (inflow)/ | Transfers to held | Foreign exchange | Fair value and | 31 st March | ||
| 2024 | outflow | Transfers | for sale | movements | other movements | 2025 | |
| £m | £m | £m | £m | £m | £m | £m | |
| Non-current assets | |||||||
Derivative financial instruments | 15 | – | (14) | – | (1) | 4 | 4 |
| Non-current liabilities | |||||||
Borrowings | (1,339) | (297) | 312 | – | 13 | 10 | (1,301) |
Derivative financial instruments | (10) | – | 1 | – | – | – | (9) |
Lease liabilities | (24) | – | 6 | – | – | (22) | (40) |
| Current assets | |||||||
Derivative financial instruments – cross currency and interest rate swaps | – | – | 13 | – | (2) | 2 | 13 |
| Current liabilities | |||||||
Borrowings | (110) | 84 | (309) | – | 2 | – | (333) |
Derivative financial instruments – cross currency and interest rate swaps | – | – | (3) | – | – | 2 | (1) |
Lease liabilities | (8) | 9 | (6) | – | – | (1) | (6) |
Net movements in assets and liabilities arising from financing activities | (204) | – | – | 12 | (5) | ||
Purchase of treasury shares | 251 | ||||||
Dividends paid to equity shareholders | 138 | ||||||
Interest paid | 148 | ||||||
Net cash outflow from financing activities | 333 |
| Warranty and | ||||
| Restructuring | technology | Other | ||
| provisions | provisions | provisions | Total | |
| £m | £m | £m | £m | |
At 1 st April 2024 | 30 | 8 | 42 | 80 |
Charge for the year | 36 | 1 | 7 | 44 |
Utilised | (24) | (2) | – | (26) |
Released | – | (2) | (1) | (3) |
At 31 st March 2025 | 42 | 5 | 48 | 95 |
Charge for the year | 17 | 2 | 8 | 27 |
Utilised | (17) | – | (2) | (19) |
Released 1 | (11) | (1) | (14) | (26) |
Transferred to liabilities classified as held for sale (note 26) | – | (5) | (4) | (9) |
At 31 st March 2026 | 31 | 1 | 36 | 68 |
| 2026 | 2025 | |
| £m | £m | |
Current | 51 | 69 |
Non-current | 17 | 26 |
Total provisions | 68 | 95 |
| Property, | Post- | Total deferred | ||||||
| plant and | employment | tax assets / | ||||||
| equipment | benefits | Provisions | Inventories | Intangibles | Tax losses | Other | (liabilities) | |
| £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 st April 2024 | 37 | (41) | 63 | 27 | (8) | 56 | (8) | 126 |
Credit / (charge) to the income statement | 22 | (12) | (19) | (13) | (4) | 25 | 1 | – |
Reclassification | – | – | (6) | 4 | – | – | 2 | – |
Tax on items taken directly to or transferred from equity | – | (8) | – | – | – | – | 10 | 2 |
Exchange adjustments | 1 | (1) | (1) | – | – | – | 4 | 3 |
At 31 st March 2025 | 60 | (62) | 37 | 18 | (12) | 81 | 9 | 131 |
(Charge) / credit to the income statement (note 9) | (63) | – | – | 2 | (8) | (38) | (16) | (123) |
Transferred to assets classified as held for sale | 5 | (1) | (1) | (1) | 12 | – | (1) | 13 |
Tax on items taken directly to or transferred from equity | – | 3 | – | – | – | – | 10 | 13 |
Exchange adjustments | (1) | (2) | – | – | – | – | (2) | (5) |
At 31 st March 2026 | 1 | (62) | 36 | 19 | (8) | 43 | – | 29 |
| 2026 | 2025 | |
| £m | £m | |
Deferred tax assets | 43 | 135 |
Deferred tax liabilities | (14) | (4) |
Net amount | 29 | 131 |
| Weighted | |
| average | |
| duration | |
| Years | |
| Pensions: | |
UK | 13 |
US | 7 |
| Post-retirement medical benefits: | |
UK | 8 |
US | 8 |
Risk | Mitigation |
| Market (investment) risk | The group’s various defined benefit pension schemes hold diversified investment portfolios, covering a range of asset classes and |
| Asset returns may not move in line with the liabilities | including exposure to different global markets. This helps ensure that no single security within the various portfolios dominates |
| and may be subject to volatility. | the return profile for the schemes. |
| In recent years the Trustee of the UK scheme has sought to consolidate the strong funding positions of the scheme, by de-risking | |
| the investment portfolio. This has typically involved reducing allocations to riskier ‘growth’ assets (such as investment in the stock | |
| market or in lower credit quality bond assets) and increasing the allocation to ‘matching’ assets. These ‘matching’ assets consist of | |
| high quality bonds (including government bonds) where their value is expected to closely match the value of the scheme’s | |
| liabilities – see further information below. This de-risking has helped reduce the volatility of the funding positions. | |
| Interest (discount) rate risk | The group’s various defined benefit pension schemes hold a high proportion of their assets in government bonds and high quality |
| Liabilities are sensitive to movements in bond yields | corporate bonds, which provide a natural hedge against interest rates. |
| (interest rates), with lower interest rates leading to an | In the UK, this interest rate hedge is achieved by holding UK government bonds (gilts) – including on a leveraged basis using gilt |
| increase in the valuation of liabilities, albeit the impact | repurchase agreements (repo) – such that the schemes are 100% hedged versus their respective ongoing funding basis. This |
| on the plan’s funding level will be partially offset by an | hedging strategy is known as Liability Driven Investing (LDI) and the use of index-linked gilts within the portfolios also enables |
| increase in the value of its bond holdings. | inflation risks to be hedged. Gilt repo positions are held across a number of large investment banks, and are collateralised daily, |
| to help reduce counterparty risk. | |
| Inflation risk | Where plan benefits provide inflation-related increases, the plan holds some inflation-linked assets which provide a natural |
| Liabilities are sensitive to movements in inflation, with | hedge against higher than expected inflation increases. |
| higher inflation leading to an increase in the valuation | In the UK, this inflation hedge is extended by the use of inflation swaps, such that the plan is 100% hedged on the plan’s funding |
| of liabilities. | basis. The swaps are held with several banks to reduce counterparty risk. |
| Longevity risk | The group has closed most of its defined benefit pension plans to new entrants, replacing them with either a cash balance plan |
| The majority of the group’s defined benefit plans | or defined contribution plans, both of which are unaffected by life expectancy. |
| provide benefits for the life of the member, so the | For the plans where a benefit for life continues to be payable, prudent mortality assumptions are used that appropriately allow |
liabilities are sensitive to life expectancy, with increases in life expectancy leading to an increase in the valuation of liabilities. | for a future improvement in life expectancy. These assumptions are reviewed on a regular basis. |
| Liquidity risk | The group’s defined benefit plans hold sufficient liquid assets to meet its cashflow obligations and the collateral requirements of |
| The pension plan may have insufficient access to cash | its inflation and interest rate hedging. This reduces the risk of being a forced seller of less-liquid assets. The UK pension plan also |
to meet its short-term cash and collateral obligations, such that adverse scenarios could force the sale of a less-liquid assets at depressed prices. | has a loan facility in place with the Company which it can access at short notice in the event of liquidity issues. |
2026 | 2025 | |||||
| UK plan | US plans | Other plans | UK plan | US plans | Other plans | |
| % | % | % | % | % | % | |
First year’s rate of increase in salaries | – | – | 2.29 | – | – | 2.29 |
Ultimate rate of increase in salaries | – | – | 2.29 | – | – | 2.29 |
Rate of increase in pensions in payment | 3.00 | – | 2.00 | 2.90 | – | 2.00 |
Discount rate | 6.20 | 5.50 | 4.21 | 5.90 | 5.40 | 3.73 |
Inflation | – | 2.20 | 2.00 | – | 2.20 | 2.00 |
• UK Retail Prices Index (RPI) | 3.20 | – | – | 3.00 | – | – |
• UK Consumer Prices Index (CPI) | 3.00 | – | – | 2.75 | – | – |
Current medical benefits cost trend rate | 6.50 | – | – | 6.50 | – | – |
Ultimate medical benefits cost trend rate | 6.50 | – | – | 6.50 | – | – |
Currently age 65 | Age 65 in 25 years | |||
UK plan | US plans | UK plan | US plans | |
Male | 87 | 86 | 89 | 88 |
Female | 89 | 88 | 92 | 90 |
| UK | US | ||||||
| UK pension | UK pension – cash | post- retirement | post- retirement | ||||
| – legacy section | balance section | medical benefits | US pensions | medical benefits | Other | Total | |
| £m | £m | £m | £m | £m | £m | £m | |
At 31 st March 2024 | 1,384 | 189 | – | 221 | – | 6 | 1,800 |
Administrative expenses | (2) | (1) | – | (2) | – | – | (5) |
Interest income | 67 | 10 | – | 11 | – | – | 88 |
Return on plan assets excluding interest | (134) | (16) | – | (4) | – | – | (154) |
Employee contributions | – | 8 | – | – | – | – | 8 |
Company contributions | 28 | 21 | 1 | 2 | – | 1 | 53 |
Benefits paid | (58) | (5) | (1) | (27) | – | (1) | (92) |
Exchange adjustments | – | – | – | (6) | – | (1) | (7) |
At 31 st March 2025 | 1,285 | 206 | – | 195 | – | 5 | 1,691 |
Administrative expenses | (2) | (1) | – | (1) | – | – | (4) |
Interest income | 74 | 13 | – | 3 | – | – | 90 |
Return on plan assets excluding interest | (32) | (5) | – | (3) | – | – | (40) |
Employee contributions | – | 7 | – | – | – | – | 7 |
Company contributions | – | 13 | 1 | 6 | 1 | 1 | 22 |
Benefits paid | (59) | (4) | (1) | (166) | (1) | – | (231) |
Exchange adjustments | – | – | – | (6) | – | – | (6) |
At 31 st March 2026 | 1,266 | 229 | – | 28 | – | 6 | 1,529 |
2026 | 2025 | |||||||
| UK | UK | UK | UK | |||||
| pension – | pension – | pension – | pension – | |||||
| legacy | cash balance | US | legacy | cash balance | US | |||
| section | section | pensions | Other | section | section | pensions | Other | |
| £m | £m | £m | £m | £m | £m | £m | £m | |
Quoted corporate bonds | 333 | 81 | 21 | 4 | 327 | 73 | 71 | 4 |
Inflation and interest rate swaps | (12) | 1 | – | – | (1) | 2 | – | – |
Quoted government bonds | 592 | 89 | 6 | – | 354 | 40 | 50 | – |
Cash and cash equivalents | 31 | 16 | 1 | 1 | 244 | 56 | 74 | 1 |
Quoted equity | – | 22 | – | – | – | 19 | – | – |
Unquoted equity | 45 | – | – | – | 53 | – | – | – |
Property | 56 | – | – | – | 56 | – | – | – |
Insurance policies | – | – | – | – | – | – | – | – |
Other | 221 | 20 | – | 1 | 252 | 16 | – | – |
Plan assets | 1,266 | 229 | 28 | 6 | 1,285 | 206 | 195 | 5 |
| UK | US | ||||||
| UK pension | UK pension – cash | post- retirement | post- retirement | ||||
| – legacy section | balance section | medical benefits | US pensions | medical benefits | Other | Total | |
| £m | £m | £m | £m | £m | £m | £m | |
At 1 st April 2024 | (1,269) | (154) | (6) | (219) | (10) | (26) | (1,684) |
Current service cost | – | (17) | – | (2) | – | (1) | (20) |
Past service credit | 14 | – | – | – | – | – | 14 |
Interest cost | (61) | (9) | (1) | (10) | – | (1) | (82) |
Employee contributions | – | (8) | – | – | – | – | (8) |
| Remeasurements due to changes in: | |||||||
Financial assumptions | 158 | 30 | – | 4 | (1) | 4 | 195 |
Demographic assumptions | (1) | – | – | – | – | – | (1) |
Experience adjustments | (9) | 5 | – | – | 1 | – | (3) |
Benefits paid | 58 | 5 | 1 | 27 | – | 1 | 92 |
Exchange adjustments | – | – | – | 6 | 1 | 2 | 9 |
At 31 st March 2025 | (1,110) | (148) | (6) | (194) | (9) | (21) | (1,488) |
Current service cost | – | (10) | – | (1) | – | – | (11) |
Past service cost 1 | – | – | – | (7) | – | – | (7) |
Interest cost | (63) | (10) | (1) | (3) | – | (1) | (78) |
Employee contributions | – | (7) | – | – | – | – | (7) |
| Remeasurements due to changes in: | |||||||
Financial assumptions | 26 | 3 | – | 2 | – | – | 31 |
Demographic assumptions | (3) | – | – | – | – | – | (3) |
Experience adjustments | (4) | (1) | – | 1 | – | – | (4) |
Benefits paid | 59 | 4 | 1 | 166 | 1 | – | 231 |
Transferred to liabilities classified held for sale | – | – | – | – | – | 6 | 6 |
Exchange adjustments | – | – | – | 6 | – | (1) | 5 |
At 31 st March 2026 | (1,095) | (169) | (6) | (30) | (8) | (17) | (1,325) |
| UK | US | ||||||
| UK pension | UK pension – cash | post- retirement | post- retirement | ||||
| – legacy section | balance section | medical benefits | US pensions | medical benefits | Other | Total | |
| £m | £m | £m | £m | £m | £m | £m | |
At 31 st March 2026 | |||||||
Defined benefit obligation | (1,095) | (169) | (6) | (30) | (8) | (17) | (1,325) |
Fair value of plan assets | 1,266 | 229 | – | 28 | – | 6 | 1,529 |
Net post-employment benefit assets and liabilities | 171 | 60 | (6) | (2) | (8) | (11) | 204 |
At 31 st March 2025 | |||||||
Defined benefit obligation | (1,110) | (148) | (6) | (194) | (9) | (21) | (1,488) |
Fair value of plan assets | 1,285 | 206 | – | 195 | – | 5 | 1,691 |
Net post-employment benefit assets and liabilities | 175 | 58 | (6) | 1 | (9) | (16) | 203 |
2026 | 2025 | |||||
| Post- employment | Employee benefit | Post- employment | Employee benefit | |||
| benefit net assets | net obligations | Total | benefit net assets | net obligations | Total | |
| £m | £m | £m | £m | £m | £m | |
UK pension – legacy section | 171 | – | 171 | 175 | – | 175 |
UK pension – cash balance section | 60 | – | 60 | 58 | – | 58 |
UK post-retirement medical benefits | – | (6) | (6) | – | (6) | (6) |
US pensions | – | (2) | (2) | 4 | (3) | 1 |
US post-retirement medical benefits | – | (8) | (8) | – | (9) | (9) |
Other | 1 | (12) | (11) | 1 | (17) | (16) |
Total post-employment plans | 232 | (28) | 204 | 238 | (35) | 203 |
Other long-term employee benefits | (2) | (3) | ||||
Total long-term employee benefit obligations | (30) | (38) |
| 2026 | 2025 | |
| £m | £m* | |
Administrative expenses | (3) | (4) |
Current service cost | (10) | (17) |
Past service (cost) / credit | (7) | 12 |
Defined benefit post-employment costs charged to operating profit | (20) | (9) |
Defined contribution plans’ expense | (31) | (25) |
Charge to operating profit | (51) | (34) |
Interest on post-employment benefits charged to finance costs | (1) | (1) |
Interest on post-employment benefits charged to investment income | 13 | 8 |
Charge to profit before tax | (39) | (27) |
| 2026 | 2025 | |
| £m | £m* | |
Return on plan assets excluding interest | (40) | (154) |
| Remeasurements due to changes in: | ||
Financial assumptions | 31 | 193 |
Demographic assumptions | (3) | (1) |
Experience adjustments | (4) | (3) |
| Remeasurements of post-employment benefit assets | ||
and liabilities | (16) | 35 |
0.1% increase | 0.1% decrease | |||
| UK plan | US plans | UK plan | US plans | |
| £m | £m | £m | £m | |
Effect of discount rate | 16 | – | (16) | – |
Effect of inflation | (15) | – | 14 | – |
Number | £m | |
| Issued and fully paid ordinary shares | ||
At 1 st April 2024 | 193,589,845 | 215 |
Share buyback | (16,302,747) | (18) |
At 31 st March 2025 and 31 st March 2026 | 177,287,098 | 197 |
| 2026 | 2025 | |
| £m | £m | |
2023/24 final ordinary dividend paid – 55.00 pence per share | – | 101 |
2024/25 interim ordinary dividend paid – 22.00 pence per share | – | 37 |
2024/25 final ordinary dividend paid – 55.00 pence per share | 92 | – |
2025/26 interim ordinary dividend paid – 22.00 pence per share | 37 | – |
Total dividends | 129 | 138 |
| Hedging reserve | |||||||
| Foreign | Fair value | ||||||
| Capital | currency | through other | Forward | Cross | Forward | Total | |
| redemption | translation | comprehensive | currency | currency | metal | other | |
| reserve | reserve | income reserve | contracts | contracts | contracts | reserves | |
| £m | £m | £m | £m | £m | £m | £m | |
At 1 st April 2024 | 13 | (15) | (19) | (4) | (1) | 62 | 36 |
Cash flow hedges – gains / (losses) taken to equity | – | – | – | 3 | 1 | (2) | 2 |
Cash flow hedges – transferred to revenue (income statement) | – | – | – | (2) | – | (41) | (43) |
Cash flow hedges – transferred to disposal of subsidiaries (income statement) | – | – | – | 1 | – | – | 1 |
Cash flow hedges – transferred to foreign exchange (income statement) | – | – | – | – | 2 | – | 2 |
Cash flow hedges – transferred to inventory (balance sheet) | – | – | – | – | – | – | – |
Fair value gains on net investment hedges taken to equity | – | 7 | – | – | – | – | 7 |
Fair value losses on investments at fair value through other comprehensive income | – | – | (2) | – | – | – | (2) |
Exchange differences on translation of foreign operations taken to equity | – | (82) | – | – | – | – | (82) |
Cancelled ordinary shares from share buyback | 18 | – | – | – | – | – | 18 |
Tax on above items taken directly to or transferred from equity | – | – | – | – | – | 10 | 10 |
At 31 st March 2025 | 31 | (90) | (21) | (2) | 2 | 29 | (51) |
Cash flow hedges – gains / (losses) taken to equity | – | – | – | 4 | (5) | (3) | (4) |
Cash flow hedges – transferred to revenue (income statement) | – | – | – | (10) | – | (23) | (33) |
Cash flow hedges – transferred to foreign exchange | – | – | – | – | 5 | – | 5 |
Fair value losses on net investment hedges taken to equity | – | (15) | – | – | – | – | (15) |
Exchange differences on translation of foreign operation taken to equity | – | (10) | – | – | – | – | (10) |
Tax on above items taken directly to or transferred from equity | – | – | – | 2 | – | 6 | 8 |
At 31 st March 2026 | 31 | (115) | (21) | (6) | 2 | 9 | (100) |
| 2026 | 2025 | |
| £m | £m | |
Revenue | 547 | 652 |
Expenses 1 | (545) | (569) |
Profit before tax from discontinued operations | 2 | 83 |
Tax expense | (7) | (20) |
(Loss) / profit from discontinued operations | (5) | 63 |
Remeasurements of post-employment benefit assets and liabilities | (1) | 2 |
Amounts (charged) / credited to hedging reserve | (4) | 3 |
Exchange differences on translation of discontinued operations | (6) | (8) |
Tax on above items | 1 | (1) |
Other comprehensive expense from discontinued operations | (10) | (4) |
| Total comprehensive (expense) / income from discontinued | ||
operations | (15) | 59 |
Net cash (outflow) / inflow from operating activities | (30) | 51 |
Net cash outflow from investing activities | (54) | (71) |
Net cash outflow from financing activities | (4) | (3) |
Net decrease in cash generated by the discontinued operations | (88) | (23) |
pence | pence | |
| (Loss) / earnings per ordinary share from discontinued operations | ||
Basic (loss) / earnings per ordinary share from discontinued operations | (3.0) | 35.8 |
Diluted (loss) / earnings per ordinary share from discontinued | (3.0) | 35.7 |
| Catalyst | |
| Technologies | |
| £m | |
| Non-current assets | |
Property, plant and equipment | 317 |
Right-of-use-assets | 21 |
Goodwill | 263 |
Other intangible assets | 48 |
Other receivables | 1 |
Deferred tax assets | 1 |
| Current assets | |
Inventories | 218 |
Taxation recoverable | 5 |
Trade and other receivables | 166 |
Cash and cash equivalents | 28 |
Assets classified as held for sale | 1,068 |
| Current liabilities | |
Trade and other payables | (178) |
Lease liabilities | (1) |
Taxation liabilities | (3) |
Provisions | (4) |
| Non-current liabilities | |
Lease liabilities | (18) |
Deferred tax liabilities | (14) |
Employee benefit obligations | (6) |
Provisions | (5) |
Trade and other payables | (1) |
Liabilities classified as held for sale | (230) |
Net assets of disposal group | 838 |
| 2025 | |
| £m | |
| Proceeds | |
Cash consideration | 597 |
Cash and cash equivalents disposed | (10) |
Net cash consideration | 587 |
Disposal costs paid | (18) |
Net cash inflow | 569 |
| Assets and liabilities disposed | |
| Non-current assets | |
Property, plant and equipment | 49 |
Right-of-use assets | 4 |
Goodwill | 3 |
| Current assets | |
Inventories | 30 |
Trade and other receivables | 38 |
Cash and cash equivalents | 10 |
Deferred tax assets | 3 |
| Current liabilities | |
Trade and other payables | (26) |
Current income tax liabilities | (2) |
Lease liabilities | (4) |
| Non-current liabilities | |
Lease liabilities | (1) |
Provisions | (2) |
Net assets disposed | 102 |
| 2025 | |
| £m | |
Cash consideration | 597 |
Deferred consideration | 7 |
Less: carrying amount of net assets sold | (102) |
Less: disposal costs | (22) |
Cumulative currency translation gain recycled from other comprehensive income | 2 |
Profit recognised in the income statement | 482 |
| Contract | |||||||
receivables | Trade receivables | ||||||
| < 30 days | 30-90 days | >90 days | |||||
At 31 st March 2026 | Total | Impaired | Not past due | overdue | overdue | overdue | Total |
Expected credit loss rate (%) | 1% | 100% | 1% | 2% | 3% | 7% | |
Gross carrying value (£ million) | 79 | 17 | 757 | 43 | 20 | 55 | 892 |
Expected credit losses (£ million) | (1) | (17) | (4) | (1) | (1) | (3) | (26) |
Net carrying value (£ million) | 78 | 866 |
| Contract | |||||||
receivables | Trade receivables | ||||||
| < 30 days | 30-90 days | >90 days | |||||
At 31 st March 2025 | Total | Impaired | Not past due | overdue | overdue | overdue | Total |
Expected credit loss rate (%) | 1% | 100% | 1% | 2% | 3% | 8% | |
Gross carrying value (£ million) | 54 | 20 | 785 | 63 | 42 | 44 | 954 |
Expected credit losses (£ million) | (1) | (20) | (4) | (1) | (1) | (3) | (29) |
Net carrying value (£ million) | 53 | 925 |
| 2026 | 2025 | |
| £m | £m | |
At beginning of year | 30 | 29 |
Charge for year | 13 | 4 |
Utilised | 1 | – |
Released | (4) | (3) |
Transferred to assets classified as held for sale | (13) | – |
At end of year | 27 | 30 |
5% depreciation 1 | 5% appreciation 1 | |||
| 2026 | 2025 | 2026 | 2025 | |
| £m | £m | £m | £m | |
Cash flow hedges | – | (8) | 1 | 7 |
Net investment hedges | 53 | 15 | (53) | (13) |
| US dollar and | Cross currency | |||
euro loans 1 | swap 2 | FX Forwards | Total | |
| £m | £m | £m | £m | |
Carrying value of hedging instruments at 31 st March 2026 | (807) | (9) | (3) | (819) |
| Change in carrying value of hedging | ||||
instruments recognised in equity during the year | (7) | (5) | (3) | (15) |
| Change in fair value of hedged items | ||||
| during the year used to determine | ||||
hedge effectiveness | 7 | 5 | 3 | 15 |
| US dollar and | Cross currency | |||
euro loans 1 | swap 2 | FX Forwards | Total | |
| £m | £m | £m | £m | |
Carrying value of hedging instruments at 31 st March 2025 | (549) | (3) | – | (552) |
| Change in carrying value of hedging | ||||
instruments recognised in equity during the year | 5 | – | 2 | 7 |
| Change in fair value of hedged items | ||||
| during the year used to determine | ||||
hedge effectiveness | (5) | – | (2) | (7) |
| Sterling/US | Sterling/ | ||||
| dollar | euro | Other | Total | ||
| £m | £m | £m | £m | ||
| Carrying value of hedging instruments | • assets | – | 1 | 1 | 2 |
at 31 st March 2026 | • liabilities | (3) | – | (1) | (4) |
| Change in carrying value of hedging | |||||
instruments recognised in equity during the year | (6) | – | – | (6) | |
| Change in fair value of hedged items | |||||
| during the year used to determine | |||||
hedge effectiveness | 6 | – | – | 6 | |
Notional amount 3 | 90 | 58 | 25 | – |
| Sterling/ | Sterling/ | ||||
| US dollar | euro | Other | Total | ||
| £m | £m | £m | £m | ||
| Carrying value of hedging instruments | • assets | 5 | – | 2 | 7 |
at 31 st March 2025 | • liabilities | (1) | – | (1) | (2) |
| Change in carrying value of hedging | |||||
instruments recognised in equity during the year | 4 | (1) | (1) | 2 | |
| Change in fair value of hedged items | |||||
| during the year used to determine | |||||
hedge effectiveness | (4) | 1 | 1 | (2) | |
Notional amount 3 | 152 | 58 | 22 | – |
| Cross currency swap | ||
| 2026 | 2025 | |
| £m | £m | |
Carrying value of hedging instruments at 31 st March 1 | 2 | 16 |
Change in carrying value of hedging instruments recognised in equity during the year | (5) | 1 |
Change in fair value of hedged items during the year used to determine hedge effectiveness | 5 | (1) |
| 2026 | 2025 | |
| £m | £m | |
Carrying value of hedging instruments at 31 st March 2 | (5) | (5) |
Amortised cost | (78) | (140) |
Fair value adjustment | 5 | 9 |
Carrying value of hedged items at 31 st March 2 | (73) | (131) |
| Change in carrying value of hedging instruments recognised in profit | ||
or loss during the year | – | 5 |
Change in fair value of hedged items during the year used to determine hedge effectiveness | (4) | 1 |
| 2026 | 2025 | |
| £m | £m | |
Expiring in more than one year | 1,000 | 1,000 |
Undrawn committed bank facilities | 1,000 | 1,000 |
| Within 1 year | 1 to 2 years | 2 to 5 years | After 5 years | Total | |
At 31 st March 2026 | £m | £m | £m | £m | £m |
Bank overdrafts | 35 | – | – | – | 35 |
Bank and other loans – principal | 20 | 497 | 332 | 501 | 1,350 |
Bank and other loans – interest payments | 50 | 45 | 59 | 34 | 188 |
Lease liabilities – principal | 6 | 5 | 11 | 15 | 37 |
Lease liabilities – principal – classified as held for sale | 2 | 2 | 6 | 16 | 26 |
Financial liabilities in trade and other payables | 2,118 | 7 | – | – | 2,125 |
Financial liabilities in trade and other payables classified as held for sale | 125 | 1 | – | – | 126 |
Total non-derivative financial liabilities | 2,356 | 557 | 408 | 566 | 3,887 |
Forward foreign exchange contracts – payments | 535 | – | – | – | 535 |
Forward foreign exchange contracts – receipts | (540) | – | – | – | (540) |
Currency swaps – payments | 1,770 | – | – | – | 1,770 |
Currency swaps – receipts | (1,777) | – | – | – | (1,777) |
Cross currency interest rate swaps – payments | 10 | 10 | 69 | 213 | 302 |
Cross currency interest rate swaps – receipts | (11) | (11) | (70) | (211) | (303) |
Interest rate swaps – payments | 3 | 3 | 80 | – | 86 |
Interest rate swaps – receipts | (1) | (1) | (79) | – | (81) |
Total derivative financial liabilities | (11) | 1 | – | 2 | (8) |
| Within 1 year | 1 to 2 years | 2 to 5 years | After 5 years | Total | |
At 31 st March 2025 | £m | £m | £m | £m | £m |
Bank overdrafts | 24 | – | – | – | 24 |
Bank and other loans – principal | 333 | – | 781 | 532 | 1,646 |
Bank and other loans – interest payments | 52 | 50 | 88 | 50 | 240 |
Lease liabilities – principal | 8 | 9 | 17 | 23 | 57 |
Financial liabilities in trade and other payables | 1,879 | 6 | – | – | 1,885 |
Total non-derivative financial liabilities | 2,296 | 65 | 886 | 605 | 3,852 |
Forward foreign exchange contracts – payments | 155 | – | – | – | 155 |
Forward foreign exchange contracts – receipts | (152) | – | – | – | (152) |
Currency swaps – payments | 971 | – | – | – | 971 |
Currency swaps – receipts | (959) | – | – | – | (959) |
Cross currency interest rate swaps – payments | 140 | 10 | 67 | 218 | 435 |
Cross currency interest rate swaps – receipts | (155) | (11) | (72) | (223) | (461) |
Interest rate swaps – payments | 69 | 3 | 80 | – | 152 |
Interest rate swaps – receipts | (66) | (1) | (78) | – | (145) |
Total derivative financial liabilities | 3 | 1 | (3) | (5) | (4) |
| Gross | |||||
| financial | Amounts | Net amounts | Amounts | ||
| assets/(liabilities) | set off | in balance sheet | not set off 1 | Net | |
At 31 st March 2026 | £m | £m | £m | £m | £m |
Derivative financial instruments – assets – current | 22 | – | 22 | (8) | 14 |
Derivative financial instruments – assets – non-current | 2 | – | 2 | (2) | – |
Derivative financial instruments – liabilities – current | (9) | – | (9) | 8 | (1) |
Derivative financial instruments – liabilities – non-current | (13) | – | (13) | 2 | (11) |
| Gross | |||||
| financial | Amounts | Net amounts | Amounts | ||
| assets/(liabilities) | set off | in balance sheet | not set off 1 | Net | |
At 31 st March 2025 | £m | £m | £m | £m | £m |
Derivative financial instruments – assets – current | 55 | – | 55 | (9) | 46 |
Derivative financial instruments – assets – non-current | 4 | – | 4 | (4) | – |
Derivative financial instruments – liabilities – current | (14) | – | (14) | 4 | (10) |
Derivative financial instruments – liabilities – non-current | (9) | – | (9) | 9 | – |
| Fair value | |||
| 2026 | 2025 | hierarchy | |
| £m | £m | Level | |
| Financial instruments measured at fair value | |||
| Non-current | |||
Investments at fair value through other comprehensive income 1 | 36 | 38 | 1 |
Derivative financial instruments – assets 2 | 2 | 4 | 2 |
Derivative financial instruments – liabilities 2 | (13) | (9) | 2 |
| Current | |||
Trade receivables 3 | 189 | 158 | 2 |
Other receivables 4 | 9 | 1 | 2 |
Cash and cash equivalents – money market funds | 280 | 435 | 2 |
Cash and cash equivalents – cash and deposits | 42 | 23 | 2 |
Derivative financial instruments – assets 2 | 22 | 55 | 2 |
Derivative financial instruments – liabilities 2 | (9) | (14) | 2 |
| Fair value | |||
| 2026 | 2025 | hierarchy | |
| £m | £m | Level | |
| Financial instruments not measured at fair value | |||
| Non-current | |||
Borrowings | (1,322) | (1,301) | – |
Lease liabilities | (24) | (40) | – |
Trade and other receivables | 59 | 58 | – |
Other payables | (7) | (6) | – |
| Current | |||
| Amounts receivable under precious metal sale | |||
and repurchase 5 | 217 | 282 | – |
Amounts payable under precious metal sale and repurchase 5 | (948) | (669) | – |
Cash and cash equivalents – cash and deposits | 214 | 440 | – |
Cash and cash equivalents – bank overdrafts | (35) | (24) | – |
Financial assets held at amortised cost | 4 | – | – |
Borrowings | (20) | (333) | – |
Lease liabilities | (4) | (6) | – |
Trade and other receivables | 762 | 862 | – |
Trade and other payables | (1,170) | (1,210) | – |
2026 | 2025 | |||||||||
| Carrying | Carrying | |||||||||
| amount | Fair value | amount | Fair value | |||||||
| £m | £m | £m | £m | |||||||
US Dollar Bonds 2025, 2027, 2028, and 2034 | 2029, | 2030, | 2031 | (386) | (343) | (592) | (571) | |||
Euro Bonds 2025, 2028, and 2036 | 20 | 30, | 2031, | 203 | 2, 2034 | (496) | (475) | (539) | (520) | |
Sterling Bonds 2025 and 2029 | (35) | (3) | (80) | (74) | ||||||
Amounts receivable under precious metal sale and repurchase agreements | 217 | 225 | 282 | 300 | ||||||
Amounts payable under precious metal sale and repurchase agreements | (948) | (927) | (669) | (687) |
Year ended 31 st March 2026 | Year ended 31 st March 2025 | |||||
PSP | RSP | Deferred Bonus 1 | PSP | RSP | Deferred Bonus 1 | |
Outstanding at the start of the year | 2,815,121 | 227,382 | 353,966 | 2,339,767 | 489,379 | 324,719 |
Awarded during the year | 1,111,269 | 4,445 | 116,978 | 1,249,978 | 76,925 | 133,185 |
Forfeited during the year | (605,296) | (38,131) | – | (349,590) | (34,667) | – |
Released during the year | (569,165) | (159,971) | (91,787) | (425,034) | (304,255) | (103,938) |
Outstanding at the end of the year | 2,751,929 | 33,725 | 379,157 | 2,815,121 | 227,382 | 353,966 |
Year ended 31 st March 2026 | ||||
PSP | Exceptional RSP 1 | Exceptional RSP 1 | Deferred Bonus | |
Fair value of shares awarded (pence) | 1,520.60 | 1,610.00 | 1,589.30 | 1,454.90 |
Share price at the date of award (pence) | 1,736.00 | 1,736.00 | 1,736.00 | 1,736.00 |
Dividend rate | 4.44% | 4.44% | 4.44% | 4.44% |
Year ended 31 st March 2025 | ||||||
PSP | Exceptional PSP 2 | Exceptional RSP 3 | Exceptional RSP 3 | Exceptional RSP 3 | Deferred Bonus | |
Fair value of shares awarded (pence) | 1,389.60 | 1,293.00 | 1,389.60 | 1,457.9 0 | 1,529.60 | 1,325.00 |
Share price at the date of award (pence) | 1,603.00 | 1,444.00 | 1,603.00 | 1,603.00 | 1,603.00 | 1,603.00 |
Dividend rate | 4.80% | 5.60% | 4.80% | 4.80% | 4.80% | 4.80% |
| 2026 | 2025 | |
| £m | £m | |
Property, plant and equipment 1 | 74 | 155 |
Other intangible assets | 7 | 28 |
| 2026 | 2025 | |
| £m | £m | |
Short term employee benefits | 7 | 8 |
Share-based payments | 4 | 2 |
Non-executive directors’ fees and benefits | 1 | 1 |
Total compensation of key management personnel | 12 | 11 |
Measure | Definition | Purpose |
Sales 1 | Revenue excluding cost of | Provides a better measure of the |
| precious metals to customers | growth of the group as revenue can | |
| and the precious metal content | be heavily distorted by year on year | |
| of products sold to customers. | fluctuations in the market prices of | |
| precious metals and, in many cases, | ||
| the value of precious metals is | ||
| passed directly on to customers. | ||
| Underlying | Operating profit excluding | Provides a measure of operating |
| operating | non-underlying items. | profitability that is comparable |
profit 1,2 | over time. | |
| Underlying | Underlying operating profit | Provides a measure of how we |
| operating profit | divided by sales. | convert our sales into underlying |
margin 2 | operating profit and the efficiency | |
| of our business. | ||
| Underlying profit | Profit before tax excluding | Provides a measure of profitability |
before tax 2 | non-underlying items. | that is comparable over time. |
| Underlying profit | Profit after tax excluding | Provides a measure of profitability |
after tax 2 | non-underlying items and | that is comparable over time. |
| related tax effects. | ||
| Adjusted | Underlying profit after tax | Provides a measure of profitability |
| underlying profit | adjusted to include the effect | that is comparable over time |
after tax 2 | of deferred tax assets not | excluding the impact of the agreed |
| recognised in H2’26 as a | sale of Catalyst Technologies. | |
| consequence of the agreed sale | ||
| of Catalyst Technologies. | ||
| Underlying | Adjusted underlying profit after | Our principal measure used to |
| earnings per | tax divided by the weighted | assess the overall profitability of |
share 1,2 | average number of shares in | the group. |
| issue. |
Measure | Definition | Purpose |
| Return on capital | Annualised underlying | Provides a measure of the group’s |
| employed | operating profit divided by the | efficiency in allocating the capital |
| (ROCE) | average equity plus average net | under its control to profitable |
| debt. The average is calculated | investments. | |
| using the opening balance for | ||
| the financial year and the | ||
| closing balance. | ||
| Average working | Monthly average of non- | Provides a measure of efficiency in |
| capital days | precious metal related | the business with lower days driving |
| (excluding | inventories, trade and other | higher returns and a healthier |
| precious metals) | receivables and trade and other | liquidity position for the group. |
| payables (including any | ||
| classified as held for sale) | ||
| divided by sales for the last | ||
| three months multiplied by | ||
| 90 days. | ||
Free cash flow 1,3 | Net cash flow from operating | Provides a measure of the cash the |
| activities (excluding disposal | group generates through its | |
| related costs) after net interest | operations, less capital expenditure. | |
| paid, net purchases of non- | ||
| current assets and investments, | ||
| and the principal element of | ||
| lease payments. | ||
| Net debt to | Net debt, including quoted | Provides a measure of the group’s |
| underlying | bonds purchased to fund the | ability to repay its debt. The group |
EBITDA 3 | UK pension (excluded when | has a current target of net debt to |
| the UK pension plan is in | underlying EBITDA of between | |
| surplus) divided by underlying | 1.5 and 2.0 times prior to the | |
| EBITDA for the same period. | completion of the CT disposal. | |
| Going forward the group is | ||
| targeting net debt to underlying | ||
| EBITDA of between 1.0 and 1.5 | ||
| times, although in any given year it | ||
| may fall outside this range | ||
| depending on future plans. |
| 2026 | 2025 | |
| £m | £m* | |
Revenue (note 3) | 12,573 | 11,022 |
Less: sales of precious metals to customers (note 3) | (10,018) | (8,191) |
Sales | 2,555 | 2,831 |
| Operating | Profit before | Profit after | ||
| profit | tax | Tax expense | tax | |
| £m | £m | £m | £m | |
Adjusted underlying | 340 | 271 | (55) | 216 |
Effect of deferred tax asset not recognised 1 | – | – | (45) | (45) |
Underlying | 340 | 271 | (100) | 171 |
Profit on disposal of businesses | 5 | 5 | – | 5 |
Gain on significant legal proceedings | 8 | 8 | (2) | 6 |
Major impairment and restructuring charges | (192) | (192) | (2) | (194) |
Share of losses of associates | – | (1) | – | (1) |
Non-underlying tax provisions | – | – | 12 | 12 |
Deferred tax asset not recognised | – | – | (90) | (90) |
Reported | 161 | 91 | (182) | (91) |
| Operating | Profit before | Profit after | ||
| profit | tax | Tax expense | tax | |
| £m | £m | £m | £m | |
Underlying | 299 | 245 | (50) | 195 |
Profit on disposal of businesses | 482 | 482 | (67) | 415 |
Major impairment and restructuring charges | (327) | (327) | 10 | (317) |
Share of profits of associates | – | 3 | – | 3 |
Non-underlying tax provisions | – | – | 14 | 14 |
Reported | 454 | 403 | (93) | 310 |
2026 | 2025* | |
Adjusted underlying profit after tax (£ million) 1 | 216 | 195 |
Weighted average number of shares in issue (number) | 168,153,798 | 175,966,787 |
Underlying earnings per share (pence) | 128.5 | 110.7 |
| 2026 | 2025 | |
| £m | £m* | |
Underlying operating profit | 340 | 299 |
Average net debt | 845 | 888 |
Average equity | 1,355 | 1,609 |
Average capital employed | 2,200 | 2,497 |
ROCE | 15.5% | 12.0% |
| 2026 | 2025 | |
| £m | £m* | |
Inventories | 865 | 1,011 |
Trade and other receivables | 1,430 | 1,532 |
Trade and other payables | (2,15 4) | (1,984) |
141 | 559 | |
Working capital balances relating to discontinued operations | – | (192) |
Total working capital | 141 | 367 |
Less: Precious metal working capital | 38 | (111) |
| Add: Precious metal working capital relating to discontinued | ||
operations | – | 8 |
Working capital (excluding precious metals) | 179 | 264 |
Average working capital days (excluding precious metals) | 62 | 52 |
| 2026 | 2025 | |
| £m | £m* | |
Net cash inflow from operating activities | 465 | 381 |
| Less: Net cash outflow / (inflow) from operating activities – | ||
discontinued operations | 30 | (51) |
Add: Disposal costs | 1 | 18 |
Add: Pension costs relating to divestments | – | 25 |
Add: Income tax paid relating to divestments | – | 64 |
Interest received | 97 | 78 |
Interest paid | (186) | (148) |
Purchases of property, plant and equipment | (217) | (249) |
Purchases of intangible assets | (22) | (52) |
Net cash movements of financial assets held at amortised cost | (4) | – |
Proceeds from redemption of investments held at fair value through other comprehensive income | 3 | 3 |
Proceeds from sale of non-current assets | 5 | 1 |
Principal element of lease payments | (4) | (6) |
Free cash flow | 168 | 64 |
| 2026 | 2025 | |
| £m | £m** | |
Cash and deposits | 256 | 463 |
Money market funds | 280 | 435 |
Bank overdrafts | (35) | (24) |
Cash and cash equivalents | 501 | 874 |
Less: Cash and cash equivalents from discontinued operations | – | (32) |
Cash and cash equivalents from continuing operations | 501 | 842 |
| Derivative financial instruments – Cross currency and interest rate | ||
swaps – non-current assets | 2 | 4 |
| Derivative financial instruments – Cross currency and interest rate | ||
swaps – current assets | – | 13 |
| Derivative financial instruments – Cross currency and interest rate | ||
swaps – current liabilities | – | (1) |
| Derivative financial instruments – Cross currency and interest rate | ||
swaps – non-current liabilities | (13) | (9) |
Borrowings – current | (20) | (333) |
Borrowings – non-current | (1,322) | (1,301) |
Lease liabilities – current | (4) | (6) |
Lease liabilities – non-current | (24) | (40) |
Less: Lease liabilities relating to discontinued operations | – | 21 |
Net debt | (880) | (810) |
| 2026 | 2025 | |
| £m | £m** | |
(Decrease) / increase in cash and cash equivalents | (349) | 345 |
Less: Decrease in cash and cash equivalents from discontinued operations | 88 | 23 |
Less: Decrease / (increase) in borrowings | 316 | (213) |
Less: Net cash movements from hedging activities | (9) | – |
Less: Principal element of lease payments | 4 | 6 |
Decrease in net debt resulting from cash flows | 50 | 161 |
New leases, remeasurements and modifications | (6) | (22) |
Less: New leases, remeasurements and modifications from discontinued operations | – | 11 |
Other lease movements | (2) | 1 |
Disposals | – | 5 |
Exchange differences on net debt | (21) | 11 |
Other non-cash movements | (8) | 16 |
Less: Other non-cash movements in discontinued operations | (83) | (28) |
Movement in net debt | (70) | 155 |
Net debt at beginning of year | (810) | (965) |
Net debt at end of year | (880) | (810) |
Underlying operating profit | 340 | 299 |
Add back: Depreciation and amortisation | 149 | 156 |
Underlying EBITDA | 489 | 455 |
Net debt to underlying EBITDA | 1.8 | 1.8 |
Underlying EBITDA | 489 | 455 |
Depreciation and amortisation | (149) | (156) |
Profit on disposal of businesses | 5 | 482 |
Gain on significant legal proceedings | 8 | – |
Major impairment and restructuring charges | (192) | (327) |
Finance costs | (182) | (141) |
Investment income | 113 | 87 |
Share of (losses) / profits of associates | (1) | 3 |
Income tax expense | (182) | (93) |
(Loss) / profit for the year from continuing operations | (91) | 310 |